Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_assertion description "[Moreover, comparing both DS and non-DS AMKL with MK, we identified three potential clinical markers of progression to AMKL: TMEM241 (transmembrane protein 241) was the most over-expressed single gene, while APOC2 (apolipoprotein C-II) and ZNF587B (zinc finger protein 587B) appear to be the most discriminant markers of progression, specifically to DS AMKL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_assertion evidence source_evidence_literature NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_assertion SIO_000772 25476127 NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_assertion wasDerivedFrom befree-2016 NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_assertion wasGeneratedBy ECO_0000203 NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.
- befree-2016 importedOn "2016-02-19" NP1244923.RASJ5fG5TU4DbKrQV8gbnGp6V75Yeq7eW_rCtPmjIzP5I130_provenance.